Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

1.0K
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
1.0K
Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

1.2K
Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
1.2K
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

1.3K
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
1.3K
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

552
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
552
Acute Respiratory Failure-IV01:23

Acute Respiratory Failure-IV

621
Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
621
Alterations in Respiration II01:30

Alterations in Respiration II

2.0K
There are numerous types of normal and abnormal respiration. Based on ventilatory movements, breathing patterns are classified as regular, deep, or shallow. Examples include Biot's breathing, Cheyne-Stokes respiration, Kussmaul's breathing, hyperventilation, and hypoventilation. Each pattern is clinically significant and aids in evaluating patients.
In Biot's breathing, the respiratory rate and depth are irregular, alternating between periods of deep gasping and apnea. Common causes...
2.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A simulation platform for small solar system bodies' gravity using the Einstein-Elevator.

The Review of scientific instruments·2026
Same author

[Development of an infusion regimen to avoid incompatibilities in adult intensive care patients].

Medizinische Klinik, Intensivmedizin und Notfallmedizin·2026
Same author

[Resuscitative endovascular balloon occlusion of the aorta (REBOA) for cesarean section in two patients with placenta accreta spectrum disorder].

Die Anaesthesiologie·2024
Same author

Statins did not reduce the frequency of exacerbations in individuals with COPD and cardiovascular comorbidities in the COSYCONET cohort.

Respiratory research·2024
Same author

Impedance-based in vitro eye irritation testing enables the categorization of diluted chemicals.

Scientific reports·2024
Same author

[Application and control of intravenous fluids in German intensive care units : A national survey among critical care physicians].

Die Anaesthesiologie·2024

Related Experiment Video

Updated: Feb 26, 2026

Surfactant Depletion Combined with Injurious Ventilation Results in a Reproducible Model of the Acute Respiratory Distress Syndrome ARDS
06:22

Surfactant Depletion Combined with Injurious Ventilation Results in a Reproducible Model of the Acute Respiratory Distress Syndrome ARDS

Published on: April 7, 2021

3.9K

[Update: acute hypercapnic respiratory failure].

F Seiler1,2, F C Trudzinski3,4, M Kredel5

  • 1Klinik für Innere Medizin V - Pneumologie, Allergologie, Intensivmedizin, Universitätsklinikum des Saarlandes, Kirrberger Str. 100, 66421, Homburg/Saar, Deutschland. frederik.seiler@uks.eu.

Medizinische Klinik, Intensivmedizin Und Notfallmedizin
|July 15, 2017
PubMed
Summary

Extracorporeal CO2 removal (ECCO2R) may help avoid intubation in hypercapnic respiratory failure when noninvasive ventilation fails. However, ECCO2R is experimental, and evidence for improved outcomes is limited.

Keywords:
ARDSECCO2RECMOHypercapnic respiratory failureHypoxemic respiratory failure

More Related Videos

A Model of Self-limited Acute Lung Injury by Unilateral Intra-bronchial Acid Instillation
07:40

A Model of Self-limited Acute Lung Injury by Unilateral Intra-bronchial Acid Instillation

Published on: August 30, 2019

9.5K
Open Tracheostomy Gastric Acid Aspiration Murine Model of Acute Lung Injury Results in Maximal Acute Nonlethal Lung Injury
09:16

Open Tracheostomy Gastric Acid Aspiration Murine Model of Acute Lung Injury Results in Maximal Acute Nonlethal Lung Injury

Published on: February 26, 2017

10.2K

Related Experiment Videos

Last Updated: Feb 26, 2026

Surfactant Depletion Combined with Injurious Ventilation Results in a Reproducible Model of the Acute Respiratory Distress Syndrome ARDS
06:22

Surfactant Depletion Combined with Injurious Ventilation Results in a Reproducible Model of the Acute Respiratory Distress Syndrome ARDS

Published on: April 7, 2021

3.9K
A Model of Self-limited Acute Lung Injury by Unilateral Intra-bronchial Acid Instillation
07:40

A Model of Self-limited Acute Lung Injury by Unilateral Intra-bronchial Acid Instillation

Published on: August 30, 2019

9.5K
Open Tracheostomy Gastric Acid Aspiration Murine Model of Acute Lung Injury Results in Maximal Acute Nonlethal Lung Injury
09:16

Open Tracheostomy Gastric Acid Aspiration Murine Model of Acute Lung Injury Results in Maximal Acute Nonlethal Lung Injury

Published on: February 26, 2017

10.2K

Area of Science:

  • Critical Care Medicine
  • Respiratory Physiology
  • Extracorporeal Therapies

Background:

  • Hypercapnic respiratory failure is common in critical care, particularly in acute exacerbation of COPD (AECOPD) and acute respiratory distress syndrome (ARDS).
  • The use of extracorporeal CO2 removal (ECCO2R) has increased for managing these conditions.

Purpose of the Study:

  • To review the current management of hypercapnic respiratory failure.
  • To specifically evaluate the role of ECCO2R in this context.

Main Methods:

  • Selective literature review.
  • Incorporation of authors' clinical and scientific expertise.

Main Results:

  • Noninvasive ventilation (NIV) is the primary treatment for AECOPD-related hypercapnic respiratory failure, improving prognosis for most patients.
  • ECCO2R may help avoid intubation or reduce mechanical ventilation duration in patients with AECOPD where NIV fails, but robust evidence is lacking.
  • In severe ARDS, ECCO2R can manage respiratory acidosis under ultra-protective ventilation, though prognostic benefits are not yet demonstrated.

Conclusions:

  • Optimized NIV and lung-protective ventilation remain the standard of care for hypercapnic respiratory failure.
  • ECCO2R is currently considered experimental and should be used in experienced centers or clinical trials.